Highbridge Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,251
Closed -$274K 564
2018
Q2
$274K Sell
4,251
-21,464
-83% -$1.41M 0.01% 730
2018
Q1
$1.6M Sell
25,715
-8,173
-24% -$586K 0.03% 464
2017
Q4
$2.46M Buy
+33,888
New +$2.46M 0.04% 357
2017
Q3
Sell
-13,928
Closed -$1.12M 1567
2017
Q2
$1.12M Sell
13,928
-110,487
-89% -$8.72M 0.02% 539
2017
Q1
$9.77M Sell
124,415
-220,349
-64% -$17.6M 0.14% 193
2016
Q4
$27.2M Buy
+344,764
New +$27.9M 0.48% 51
2015
Q4
Sell
-34,547
Closed -$3.38M 1542
2015
Q3
$3.33M Buy
+34,547
New +$3.63M 0.05% 398
2015
Q2
Sell
-222,107
Closed -$22.7M 1446
2015
Q1
$22.9M Buy
+222,107
New +$22.5M 0.32% 86
2014
Q3
Sell
-81,579
Closed -$6.15M 1231
2014
Q2
$6.15M Buy
81,579
+58,451
+253% +$4.42M 0.07% 239
2014
Q1
$1.73M Buy
+23,128
New +$1.63M 0.02% 445
2013
Q4
Sell
-506,388
Closed -$28.7M 1105
2013
Q3
$28.7M Buy
506,388
+200,570
+66% +$12M 0.3% 95
2013
Q2
$17.5M Buy
+305,818
New +$17.7M 0.17% 149

Other funds holding CVS

Highbridge Capital Management's CVS Position: Q3 2018 in Review

Highbridge Capital Management sold out of CVS Health (CVS) in Q3 2018, closing a stake of 4,251 shares — an estimated $274K sold.

Highbridge Capital Management first reported a position in CVS in Q2 2013 and held it in 12 quarters. The position peaked at $28.7M in Q3 2013. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

  • Highbridge Capital Management reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 4,251 CVS Health shares in Q3 2018, an estimated $274K.
  • Highbridge Capital Management first reported a position in CVS Health in Q2 2013 and held it in 12 quarters.
  • Highbridge Capital Management's CVS Health position peaked at $28.7M in Q3 2013.
  • 1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.